How effective is Rebif for Relapsing-remitting Multiple Sclerosis? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.4/5
This is a phase IV clinical study of how effective Rebif (interferon beta-1a) is for Relapsing-remitting multiple sclerosis and for what kind of people. The study is created by eHealthMe from 37 Rebif users and is updated continuously.
What is Rebif?
Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. eHealthMe is studying from 61,126 Rebif users. Check the latest studies of Rebif.
What is Relapsing-remitting multiple sclerosis?
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 127 drugs and 177 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.
37 people are studied for taking Rebif in Relapsing-remitting multiple sclerosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Rebif effectiveness for Relapsing-remitting multiple sclerosis (number of people):
Overall:
- not at all: 2
- somewhat: 4
- moderate: 13
- high: 16
- very high: 2
Long Term:
- not at all: 2
- somewhat: 3
- moderate: 5
- high: 15
- very high: 1
Gender of people who take Rebif for Relapsing-remitting multiple sclerosis *:
- female: 83.78 %
- male: 16.22 %
Age of people who take Rebif for Relapsing-remitting multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 10.81 %
- 30-39: 24.32 %
- 40-49: 40.54 %
- 50-59: 21.62 %
- 60+: 2.7 %
Who find Rebif more effective for Relapsing-remitting Multiple Sclerosis?
Gender of people who take Rebif for Relapsing-remitting multiple sclerosis *:
- female: 77.78 %
- male: 22.22 %
Age of people who take Rebif for Relapsing-remitting multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 5.5600000000000005 %
- 30-39: 27.78 %
- 40-49: 38.89 %
- 50-59: 22.22 %
- 60+: 5.5600000000000005 %
* Approximation only. Some reports may have incomplete information.
Do you take Rebif?
- You can start a phase IV clinical trial to monitor Rebif safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Rebif (61,126 reports)
Treatments, associated drugs and conditions:
- Relapsing-remitting multiple sclerosis (76,275 reports)
How the study uses the data?
The study is based on interferon beta-1a (the active ingredients of Rebif) and Rebif (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metformin cause Renal Cell Carcinoma? - a second ago
- Could Clotrimazole cause Mental Status Changes? - 2 seconds ago
- Colon Cancer and Supraventricular Extrasystoles - 4 seconds ago
- Could Rocephin cause Pain In Jaw? - 5 seconds ago
- Drug interactions of Progesterone and Probiotic - 8 seconds ago
- Could Tranexamic Acid cause Joint Pain? - 10 seconds ago
- Could Leucovorin Calcium cause Blood Creatinine Increased? - 10 seconds ago
- Could Levaquin cause Drug Toxicity? - 10 seconds ago
- Could Levaquin cause Jaw Fracture? - 11 seconds ago
- Could Metoprolol Succinate cause Coronary Heart Disease? - 13 seconds ago